AC Immune SA ACIU
NASDAQ · United States · Health Technology
$2.73-0.08 (-3.02%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.02 | 0.12 | -79.6% | $18.70M | -45.1% | +2.2%$2.27→$2.32 |
| Q1 2026 | 2026-04-30 | -0.19 | -0.20 | +5.0% | — | — | +1.7%$2.93→$2.98 |
| Q4 2025 | 2026-03-13 | -0.14 | -0.17 | +17.6% | — | — | +4.3%$3.00→$3.13 |
| Q3 2025 | 2025-11-04 | -0.20 | -0.22 | +9.1% | — | — | +7.9%$3.18→$3.43 |
| Q4 2024 | 2025-03-13 | -0.16 | -0.19 | +15.8% | — | — | — |
| Q3 2024 | 2024-11-05 | 0.05 | -0.19 | +126.3% | — | — | — |
| Q1 2024 | 2024-05-13 | -0.18 | -0.12 | -50.0% | — | — | — |
| Q4 2023 | 2024-03-14 | -0.05 | -0.16 | +68.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.